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Abstract
Cardiospheres (CSps) are self‐assembling clusters of a heterogeneous population of
poorly differentiated cells outgrowing from in vitro cultured cardiac explants. Scanty
information is available on the molecular pathways regulating CSp growth and their
differentiation potential towards cardiac and vascular lineages. Here we report that
Notch1 stimulates a massive increase in both CSp number and size, inducing a pecu-
liar gene expression programme leading to a cardiovascular molecular signature.
These effects were further enhanced using Adeno‐Associated Virus (AAV)‐based
gene transfer of activated Notch1‐intracellular domain (N1‐ICD) or soluble‐Jagged1
(sJ1) ligand to CSp‐forming cells. A peculiar effect was exploited by selected pro‐
proliferating miRNAs: hsa‐miR‐590‐3p induced a cardiovascular gene expression pro-
gramme, while hsa-miR-199a-3p acted as the most potent stimulus for the activa-
tion of the Notch pathway, thus showing that, unlike in adult cardiomyocytes, these
miRNAs involve Notch signalling activation in CSps. Our results identify Notch1 as a
crucial regulator of CSp growth and differentiation along the vascular lineage, raising
the attracting possibility that forced activation of this pathway might be exploited
to promote in vitro CSp expansion as a tool for toxicology screening and cell‐free
therapeutic strategies.
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1 | INTRODUCTION
The heart of adult mammals has a limited capacity of replacing dam-
aged tissue after injury. Understanding the molecular mechanisms of
cardiomyocyte proliferation during development, as well as of the
incapacity of mature cardiomyocytes to divide in adult mammals, is a
pre‐requisite for the development of innovative approaches to pre-
vent loss of functional myocardium after injury.
Experimental evidence over the past few years has suggested that
cardiac regeneration might be achieved by directly stimulating the
proliferation of committed cardiac progenitors, or even of fully differ-
entiated cardiomyocytes.1,2 However, cell cycling is very low in adult
cardiomyocytes and myocardial repair after damage usually involves
scarring and fibrosis, which frequently leads to heart failure. Thus, the
identification of strategies capable of inducing cardiac tissue regener-
ation by sustaining cardiomyocyte generation would be of paramount
importance. In recent years, multiple laboratories have independently
reported on the identification of resident cardiac progenitor cells
(CPCs) on the basis of the expression of cell‐surface markers such as
stem cell antigen‐1 (Sca‐1) or c‐Kit, and co‐expression of early
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cardiac‐specific transcription factors such as Gata4 or Nkx2.5 (for a
review see3). These cells have been used in several cell therapy
approaches aiming at promoting regeneration of damaged hearts (for
a review see4,5). The functional benefits of transplanted CPCs have
been mainly ascribed to indirect paracrine mechanisms mediated by
secreted factors, as opposed to direct generation of new cardiomy-
ocytes6,7).
In the context of cardiac progenitor cell proliferation and expan-
sion, a crucial role is played by the Notch signalling pathway, a well‐
conserved cell‐to‐cell communication system that critically regulates
embryonic heart development.8,9 Most specifically, Notch regulates
cardiomyocyte proliferation during development and in the early
postnatal life. In particular, we and others have shown that the
Notch pathway promotes the proliferation of committed precursor
cells and immature cardiomyocytes10,11 and is essential for the
maintenance of the heart structural and functional integrity after
damage in mammals as well as in lower vertebrates,12,13 in which it
has been identified as a central mechanism in heart regenera-
tion.14,15 In CPCs, Notch activation prevents premature cardiomyo-
genic differentiation, while promoting proliferation in transient
amplifying populations;16,17 conversely, inhibition of the Notch path-
way is required to promote cardiac mesoderm differentiation in
embryonic stem cells.18 Committed undifferentiated progenitor cells
can be clonally expanded from myocardial biopsy specimens and
cultured in vitro as tridimensional spheroids.19,20 Cardiospheres
(CSps) are cardiac‐derived multicellular clusters, considered a reliable
in vitro model of the cardiac microenvironment, hosting a reservoir
of both immature and committed progenitors towards the three
major cardiac cell lineages: cardiomyocytes, endothelial cells (ECs)
and smooth muscle cells (SMCs).21 CSps transplantation into
infarcted hearts results in enhanced in vivo cell survival and cardio-
protection.22 Recent data have shown that activation of the Notch
signalling pathway promotes cell differentiation along the vascular
smooth muscle lineage in CSp‐derived cells and is sensitive to oxy-
gen tension in the tridimensional cellular array.23
In this work, we aimed at dissecting the specific role of Notch1
signalling in CSps. We report that Notch1 stimulation by soluble
Jagged‐1 triggers a massive increase in both number and size of
in vitro cultured CSps. This effect was paralleled by a significant
increase in vascular developmental markers such as Flt‐1, Kdr and
CD31 and the adoption of a specific gene expression signature.
Conversely, the γ‐secretase inhibitor, DAPT, which impairs Notch1
activation, effectively blunted in vitro growth of sJ1‐stimulated
CSps, as well as modulated their gene expression pattern. These
effects were further enhanced using Adeno‐associated virus (AAV)‐
based gene transfer of activated Notch1‐intracellular domain (N1‐
ICD) or the soluble‐Jagged1 ligand (sJ1) to CSp‐forming cells. These
viral vectors possess the exquisite capacity to transduce cardiac‐
derived cells at very high efficiency and drive sustained transgene
expression.24,25
Finally, a whole‐genome, synthetic miRNA screening previously
conducted in our laboratory has identified a pool of human miRNAs
capable of inducing significant proliferation in rodents
cardiomyocytes.26 Notably, the molecular mechanisms by which
these miRNAs function in adult cardiomyocytes do not involve reac-
tivation of the Notch pathway.24 We found that, among all tested
miRNAs, hsa‐miR‐590‐3p was the most powerful inducer of a cardio-
vascular gene expression programme in CSps, leading to a significant
increase in both early (Gata4, Nkx2.5) and late cardiac markers
(Myh6), as well as of vascular markers (CD31).
Collectively, our results identify Notch1 as a crucial regulator of
CSps growth and differentiation along the vascular lineage, raising
the possibility that forced activation of this signalling pathway might
be exploited to promote in vitro CSps growth not only for therapeu-
tic purposes but also as a tool for evaluating novel cell‐free thera-
peutic strategies (for example, those based on the delivery of
exosomes or miRNAs).
2 | METHODS
2.1 | Animals
C57bl/6 and CD1 mice were purchased from Charles River Laborato-
ries Italia Srl and maintained under controlled environmental condi-
tions. Animals were housed and handled according to institutional
guidelines in compliance with national and international laws and
policies. Experimental procedures were approved by the ICGEB Ani-
mal Welfare Board and Ethical Committee, with full respect to the
EU Directive 2010/63/EU for animal experimentation.
2.2 | Culture of rodent cardiospheres
CSps were obtained and cultured as previously described.27 Briefly,
isolated myocardial tissue was cut into 1‐2 mm3 pieces, washed in
PBS and digested 3 times for 5 minutes at 37°C with 0.2% trypsin
(Invitrogen, Carlsbad, Ca, USA). Following trypsin inactivation in
complete explant medium (CEM) (Iscove's Modified Dulbecco's Med-
ium [IMDM] supplemented with 20% fetal bovine serum, 100 U/mL
penicillin G, 100 μg/mL streptomycin, 2 mmol/L L‐glutamine and
0.1 mmol/L 2‐mercaptoethanol), tissue fragments were cultured as
explants in CEM at 37°C and 5% CO2. After approximately 2 weeks,
a layer of fibroblast‐like cells was generated from adherent explants
over which small, phase‐bright cells migrated. These phase‐bright
cells were collected by pooling 2 washes with Ca2+‐Mg2+‐free PBS, 1
wash with 0.53 mmol/L EDTA (Versene, Invitrogen) (2 minutes), and
1 wash with 0.5 g/L trypsin and 0.53 mmol/L EDTA (Invitrogen) (2‐
3 minutes) at room temperature under visual control. The cells
obtained (from 104 to 4 x 105 cells/explant) were seeded at 1‐
2 x 104 cells/mL in poly‐D‐lysine‐coated multiwell plates (BD Bio-
sciences, Franklin Lakes, NJ, USA) in CSp‐growing medium (CGM‐
35% complete IMDM/65% DMEM‐Ham F‐12 mix containing 2%
B27, 0.1 mmol/L 2‐mercaptoethanol, 10 ng/mL epidermal growth fac-
tor,28 20 ng/mL basic fibroblast growth factor [bFGF], 40 nmol/L car-
diotrophin‐1, 40 nmol/L thrombin, antibiotics and L‐Glu, as in CEM).
Isolation of the CSp‐forming cells was performed from the same
explant at least 4 times at 6‐10 days intervals.
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2.3 | miRNA transfection
MicroRNAs were obtained from Dharmacon, Thermo Scientific and trans-
fected into CSp‐forming cells contextually to plating on poly‐K coated
dishes using a standard reverse transfection protocol.26 Briefly, the trans-
fection reagent (Lipofectamine RNAiMAX, Life Technologies, Carlsbad, Ca,
USA) was diluted in OPTIMEM (Life Technologies) and added to the miR-
NAs (at a final concentration of 25 nmol/L each nucleic acid), arrayed on
96‐well plates. Thirty minutes later, 1 x 104 cells were seeded per well.
Twenty‐four hours after transfection, culture medium was replaced by
fresh medium. Cells were fixed 3, 5 and 7 days after plating and processed
for further analyses. Experiments were performed in quadruplicate.
2.4 | RNA isolation and quantitative real‐time PCR
Total mRNA was purified from CSps at days 3, 5 and 7 of culture.
mRNA (1 μg) was reverse‐transcribed using MLV‐RT (Invitrogen) with
random hexamers (10 μmol/L) in a 20‐μL reaction, following the manu-
facturer's instruction. mRNA levels for Notch1, Notch2, Notch3,
Notch4, Jagged1, Jegged2, Delta‐like1, Delta‐like3, Delta‐like4, Hes1,
Hey1, Sca‐1, CD117, CD31, Flt1, Kdr, Nkx2.5, Gata4, Myh6, Neurl1a,
Dner and HPRT genes (TaqMan assays listed in Table 1) were quanti-
fied by real‐time PCR, performed with a standard probe protocol (from
60 to 95°C), according to manufacturer's instruction. The housekeep-
ing gene HPRT was used for normalization with predesigned TaqMan
assay (Applied Biosystems, Foster City, Ca, USA) and iQ Supermix (Bio-
rad, Hercules, Ca, USA). mRNA levels for N1ICD and sJ1 transgenes
were quantified by quantitative real‐time PCR (primer sequences listed
in Table 2) and GoTaq qPCRMater Mix (Promega, Madison, Wi, USA).
2.5 | Immunocytochemical staining
CSps were fixed with 4% paraformaldehyde for 10 minutes, permeabi-
lized with 0.1% Triton X‐100 in phosphate buffered saline (PBS) for
10 minutes, followed by 1 hour blocking in 2% BSA (Roche, Basel,
Switzerland) in PBS. BrdU staining of CSps pulsed 8 hours prior fixation
with 10‐μmol/L BrdU, was performed according to the manufacturer's
instructions (BD Biosciences). Cells were then stained overnight at 4°C
with the following primary antibodies diluted in blocking solution: rab-
bit polyclonal anti‐Notch1 (C20R-Santa Cruz, Dallas, Texas, USA),
1:100; rabbit polyclonal anti‐Notch2 (C20R-Santa Cruz, Dallas, Texas,
USA), 1:100; rabbit polyclonal anti‐Val1744 (Cell Signaling, Danvers,
Massachusetts, USA), 1:100; rabbit polyclonal anti‐Jagged1 (Santa
Cruz, Dallas, Texas, USA), 1:100; goat polyclonal anti‐Dll1 (C20R-Santa
Cruz, Dallas, Texas, USA), 1:50; rabbit polyclonal anti‐Hes1 (Chemicon,
Temecula, Ca, USA), 1:100; rat monoclonal anti‐BrdU (BU1/75) 1:100
(AbCam, Cambridge, UK). Cells were washed with PBS and incubated
for 1 hour with the respective secondary antibodies (goat anti‐mouse
conjugated to Alexa Fluor 488; goat anti‐rabbit conjugated to Alexa
Fluor 594; goat anti‐rat conjugated to Alexa Fluor 594). All washes
were in PBS 0.2% Tween 20. When indicated, cells were further pro-
cessed using the Click‐IT EdU 555 Imaging kit to reveal EdU incorpora-
tion, according to the manufacturer's instructions, and stained with
Hoechst 33342 (Life Technologies).
2.6 | Image acquisition and analysis
Images were acquired at room temperature with a DMLB upright fluo-
rescence microscope (Leica, Wetzlar, Germany) equipped with a charge‐
coupled device camera (CoolSNAP CF; Roper Scientific, Trenton, NJ,
USA) using MetaView 4.6 quantitative analysis software (MDS Analyti-
cal Technologies, Sunnyvale, Ca, USA). For image acquisition, the
following objectives were used: HCX PL Fluotar 100x/1.30 NA, HCX PL
apocromatic 63x/1.32‐0.6 NA, HCX PL Fluotar 40x/0.75 NA, HCX PL
N‐Plan 20x/0.40 NA and HCX PL N‐Plan 10x/0.25 NA (all from Leica).
Within each experiment, instrument settings were kept constant.
2.7 | AAV vector production and transduction
The AAV vectors used in this study were generated by the AAV
Vector Unit (AVU) at ICGEB Trieste (http://www.icgeb.org/avu-core-
facility.html) according to established procedures. All vectors were
TABLE 1 TaqMan real‐time PCR assays used to analyse gene
expression levels
Notch1 Mm00627185_m1
Jagged1 Mm00496902_m1
Notch2 Mm00803077_m1
Delta‐like1 Mm01279269_m1
Hes1 Mm01342805_m1
Hey1 Mm00468865_m1
Hey2 Mm00469280_m1
CD117 Mm00445212_m1
Sca‐1 Mm00485928_m1
CD31 Mm01242584_m1
Flt1 Mm00438980_m1
Kdr Mm01222421_m1
NKx2.5 Mm01309813_s1
Gata4 Mm00484689_m1
Myh6 Mm00440359_m1
Notch3 Mm01345646_m1
Notch4 Mm00440525_m1
Jag2 Mm01325629_m1
Dll3 Mm00432854_m1
Dll4 Mm00444619_m1
Dner Mm00548872_m1
Neurl1a Mm00480473_g1
TABLE 2 Primers used to analyse gene expression levels
sJ1 Forward ATTTCTGCTGAAGATATAGCCC
Reverse CTCCATTTCATTCAAGTCCTC
N1ICD Forward AGCAAGGAAGCTAAGGACC
Reverse CTCCATTTCATTCAAGTCCTC
HPRT Forward CAGTCAACGGGGGACATAAA
Reverse GGGCTGTACTGCTTGACCAA
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based on the AAV2 genome and transgene expression was driven by
the cytomegalovirus immediate/early promoter. CSp‐forming cells
were transduced with AAV6‐Control, AAV6‐sJ1, AAV6‐N1ICD or
AAV6‐GFP contextually to plating on poly‐lysine coated dishes, at a
multiplicity of infection (m.o.i.) of 1 x 105 vg/cell.
2.8 | Statistical analysis
All data are presented as mean ± standard error of the mean (SEM).
Statistical analysis was carried out with Prism Software (GraphPad)
using one‐way ANOVA followed by Bonferroni's post hoc test for
comparisons of 3 or more groups.
3 | RESULTS
3.1 | CSps as an in vitro culture model of heart cell
precursors
Notch regulates cardiomyocyte proliferation during development and
in the early postnatal life. We and others have previously shown that
the Notch pathway promotes the proliferation of committed precur-
sors and immature cardiomyocytes.10,16,29,30 We thus investigated
the specific role of Notch signalling in the pool of cardiac‐resident
precursor cells in the murine CSp model19,27 (Figure 1A). Analyses
were performed at three time points: 3 days after cell plating (the
time point of earliest CSp formation), 5 days after plating (the time
point of fully CSp assembly) and 7 days after plating (the time point
at which most CSps stop increasing in number and size; Figure 1B).
To characterize the cell differentiation programme during CSp forma-
tion, we analysed expression of genes related to stemness (CD117
and Sca‐1), cardiac commitment (Nkx2.5, Gata4, Myh6) and endothe-
lial specification (CD31, Flt1 and KDR). The real‐time PCR results
shown in Figure 1C led us to identify three main cell populations.
1. The bell-shaped expression profile of both CD117 and Sca-1
demonstrated the persistence, during the CSp aggregation pro-
cess, of a pool of Sca1+ progenitors, which decreased after one
week of culture.
2. The expression of the endothelial marker CD31, together with
VEGF receptors 1 and 2 (Flt1 and KDR, respectively) demon-
strated the presence of cells with vasculo-endothelial commit-
ment potential.
3. Nkx2.5, Gata4 and Mhy6 expression identified a third pool of
cells characterized by cardiac differentiation markers.
Collectively, these evidences were consistent with the notion
that CSps actually represent a valuable in vitro model of early car-
diac development.
3.2 | Notch signalling components in CSps
To investigate a possible role of the Notch pathway during CSp for-
mation, we analysed the expression levels of the Notch receptors
(Notch1, Notch2), their ligands (Jagged1, Delta‐like1) and their target
genes (Hes1, Hey1, Hey2) at 3, 5 and 7 days after plating (a panel of
all the members of the receptor and ligand family are shown in Fig-
ure S1). Figure 2A shows that both Notch1 and 2 receptors as well
as the Jagged1 and Dll‐1 ligands were expressed with a bell‐shaped
pattern during CSp formation. Hey2 showed an expression profile
superimposable to that of Notch1 and 2. Hes1 expression declined
during CSp formation, while Hey1 showed the opposite pattern.
These data suggest that Hes1 and Hey proteins may play different
roles in the CSp differentiation programme. Hes1 is the main Notch
effector during embryonic heart development and morphogenesis,
and Hey2 plays an important role in the regulation the cardiovascu-
lar development. Conversely, Hey1 exerts its role of transcriptional
activator during vasculogenesis, angiogenesis and blood vessel devel-
opment.31 Therefore, it is intriguing that the expression of Hey1
increases during CSp formation, in parallel with the observed
increase in the expression of VEGFR genes (Figure 1C).
One major constrain of real‐time PCR analysis is that the cell‐type
expressing a given gene is not precisely identified. To address this issue,
we performed immunostaining experiments on CSps after 5 days of
culture, a time point at which sphere formation is complete and all our
genes of interest are expressed at significant levels. Notch2 showed a
diffuse localization pattern within the CSp, while immmunodetection of
both Notch1 and its ligand Jagged1 revealed a more patchy distribu-
tion; Delta‐like1 was localized mainly in the outer layer of CSps (Fig-
ure 2B, C, D panel c and d). The expression of both Notch1 and Notch2
receptors, as well as that of Jagged1 and Dll‐1, was also observed in
substrate‐adherent CSp‐forming cells (Figure 2E).
We also investigated the subcellular localization of Hes1 and N1‐
ICD, two key players of the activated Notch pathway. Hes1 showed
a diffuse staining in the inner part of CSps, while activated N1‐ICD
(detected by an antibody raised against the first amino acids of its
cleaved intracellular domain) exhibited significant co‐localization with
Notch1 (Figure 2D panels a and b). These results suggested an active
role of Notch signalling in CSp formation and maturation.
3.3 | Stimulation of the Notch pathway enhances
CSp growth
In several models of stem cell in vitro culture, Notch expression co‐
localizes with pools of proliferating cells.18,32,33 To directly assess
this issue, we cultured CSps in the presence of the conditioned med-
ium from NIH‐3T3 cells secreting a soluble form of Jagged1 (sJ1; 34).
In a mirror experiment, we treated cells with the γ‐secretase inhibi-
tor, DAPT, to investigate whether blocking Notch activation impairs
CSp formation and growth.
The effect of sJ1 has been extensively characterized in our labo-
ratory.10,24,35 Current evidence suggests that sJ1 may spontaneously
cluster on the surface of the target cells by virtue of its interactions
with various proteins of the extracellular matrix and cell surface, as
described for other soluble growth factors (for a review see36-38).
sJ1 therefore could activate Notch signalling acting as a soluble
cytokine.
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Exposure to sJ1 at 3 or 5 days after cell plating significantly
boosted the aggregation capacity of CSp‐forming cells; however,
this effect was blunted when sJ1 was added to cells 7 days
after plating. On the other hand, DAPT treatment strongly
reduced the number of CSps formed at any time point (Fig-
ure 3A, B). Notch pathway activation showed a remarkable effect
not only on the total number of CSps, but also on their size.
sJ1 treatment significantly increased the cross‐sectional area of
CSps, whereas DAPT significantly decreased their overall
diameter at day 5 of culture (Figure 3C). The number of BrdU‐
positive cells in CSps was increased in sJ1‐stimulated conditions
after 5 days of culture, which was paralleled by increased
expression of the Notch1 receptor (Figure 3D, panel a and b for
quantification).
Collectively, these results strongly support the conclusion that
Notch1 activation powerfully stimulates the proliferation and expan-
sion of CSp‐forming cells at early times of culture; however, this
effect progressively decreases during CSp differentiation.
F IGURE 1 Derivation and characterization of cardiospheres. A, Schematic diagram showing derivation and culture of cardiospheres; B,
Representative bright field images of primary cardiospheres at 3, 5 and 7 days after plating; scale bars: 100 μm. C, Gene expression profile of
cultured cardiospheres at days 3, 5 and 7 after plating. Shown are the mean ± SEM of at least 3 independent experiments. *P < 0.05;
**P < 0.01
SECCO ET AL. | 5587
3.4 | Stimulation of the Notch pathway promotes a
cardiovascular gene expression programme in
growing CSps
To further investigate the signalling network downstream Notch
activation, which enhances CSp growth, we analysed gene expres-
sion profiles of CSps after 3, 5 and 7 days of culture in the pres-
ence of either sJ1 or DAPT. sJ1 triggered a net increase in the
expression of both Notch receptors (Notch1 and ‐2) and ligands
(Jagged1 and Delta‐like1), consistent with the existence of a positive
feed‐back loop,13,39 whereas γ‐secretase inhibition reduced their
overall levels.
We also assessed mRNA expression levels for endogenous Notch
targets. Gene expression of Hes1 and, to a lesser extent, Hey2 (two
major transducers of Notch signalling during heart development) par-
alleled the increase in CSp growth (Figure S2). We next analysed the
expression of genes related to stemness, blood vessel or heart devel-
opment. Figure 3E shows that sJ1 stimulation markedly increased
expression levels of the genes involved in angiogenesis, such as
CD31 and VEGF receptors 1 and 2. In addition, sJ1 stimulation was
associated with increased expression of Nkx2.5, the master gene for
cardiac development, but decreased Gata4 expression, in agreement
with published data.16,40 Unexpectedly, Sca1 expression increased
after sJ1 stimulation.
These results support the notion that CSp differentiation
requires a fine tuning of the Notch pathway. As demonstrated
under different experimental conditions, Notch signalling must be
turned off in order to trigger committed progenitor cell differenti-
ation into a fully cardiac phenotype.8,41 On the other hand,
hypoxia associated with the tridimensional array of cells typical of
CSps greatly favours the activation of the Notch pathway and the
expansion of the pool of proliferating cells responsible for the sus-
tained growth in vitro.18
3.5 | Activation of the Notch pathway by AAV‐
mediated gene transfer promotes CSp growth
Given the effect of the exogenous stimulation of the Notch path-
way by sJ1 on CSps number and size, we asked whether the
forced and sustained activation of the Notch pathway using a gene
transfer approach would enhance these effects. We took advantage
of the ability of AAV‐vectors, serotype 6 (AAV6), to transduce car-
diac cells at high efficiency (Figure 3A; 25). We used two AAV6
vectors, one coding for the constitutively active Notch1 intracellular
F IGURE 2 Expression of the Notch pathway components in cardiospheres. A, Gene expression analysis of Notch pathway components in
cultured cardiospheres analysed at days 3, 5 and 7 after plating. Shown are the means ± SEM of at least 3 independent experiments.
**P < 0.01; *P < 0.05. B, Immunolocalization of Notch receptors in cardiospheres after 5 days of culture. Representative images of
cardiospheres stained for Notch1 (green), Notch2 (red); nuclei are visualized in blue by Hoechst. Bars: 40 μm. C, Same as in panel B for the
Jagged1 ligand. Jagged1 (red); nuclei are visualized in blue by Hoechst. Bars: 40 μm. D, Same as in panel B for (a) Notch1 (green) and Hes1
(red); (b) Notch1 (green) and N1‐ICD (Val 1744‐red); (c) Jagged1 (red) and Notch1 (green); (d) Dll1 (green) and Notch2 (red). Nuclei are
visualized in blue by Hoechst. Bars: 40 μm. E, Immunolocalization of Notch receptors and ligands in CDCs. Representative images of
cardiospheres stained for Notch1, Notch2, Jagged1 and Dll‐1 (red); nuclei are visualized in blue by Hoechst. Bars: 40 μm
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F IGURE 3 Stimulation of the Notch pathway enhances cardiosphere growth and induces a cardiovascular differentiation programme.
Cardiosphere‐forming cells were treated either with the soluble form of Jagged1 (sJ1) or with DAPT for 24 h before the analysis after 3, 5 and
7 days of in vitro culture A, Representative bright field images of cardiospheres, treated either with 20x sJ1 or DAPT, after 3, 5 and 7 days of
in vitro culture. Scale bar: 100 μm. B, Quantification of the number cardiospheres treated either with 20x sJ1 or DAPT, after 3, 5 and 7 days
of in vitro culture. Shown are mean ± SEM of at least 3 experimental replicates ***P < 0.001; **P < 0.01. C, Distribution of the cross‐
sectional areas of the cardiospheres, treated either with 20x sJ1 or DAPT, after 3, 5 and 7 days of in vitro culture. Shown are Tukey boxplots,
**P < 0.01. D, (a) Representative images of BrdU+ cells in cardiospheres after 5 days of in vitro culture in the presence of 20X sJ1 or DAPT.
BrdU (green), Notch1 (red), Nuclei (blue). Scale bar 40 μm. (b) Quantification of BrdU+ cells upon sJ1 or DAPT treatment. Shown are
mean ± SEM of at least 3 experimental replicates. **P < 0.01: *P < 0.05. E, Transcription levels of indicated genes in cardiospheres analysed
at day 3, 5 and 7 of in vitro culture, in the presence of either 20x sJ1 or DAPT. Data are expressed to cellular HPRT mRNA levels. Shown are
the mean ± SEM of at least 3 independent experiments. **P < 0.01: *P < 0.05
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domain (AAV6‐N1ICD; 10) and the other coding for the soluble
form of the ligand Jagged1 (AAV6‐sJ1; 24), which activates Notch
signalling acting as a soluble cytokine.10,42 CSp‐forming cells were
transduced contextually to their plating (m.o.i = 1 x 105 vg per cell)
with either vector. Analyses were performed at 3, 5 and 5 days
after plating. Sustained transgene expression was demonstrated
with both vectors (Figure S3B).
Both AAV6‐N1ICD and AAV6‐sJ1 markedly increased both
total numbers and size of CSps at all time points (Figure 4A, B,
C). The observed different kinetics between the two vectors most
F IGURE 4 Stimulation of the Notch pathway through AAV6‐N1ICD or AAV6‐sJ1 transduction enhances cardiosphere growth and induces a
cardiovascular differentiation programme. Cardiosphere‐forming cells were transduced contextually to plating with either AAV6‐MCS, ‐N1ICD
or ‐sJ1 vectors (m.o.i = 1 x 105). A, Representative bright field images of cardiospheres, transduced either with AAV6‐MCS, ‐N1ICD or ‐sJ1,
after 3, 5 and 7 days of in vitro culture. Scale bar: 100 μm. B, Quantification of the number cardiospheres transduced either with AAV6‐MCS, ‐
N1ICD or ‐sJ1, after 3, 5 and 7 days of in vitro culture. Shown are mean ± SEM of at least 3 experimental replicates. C, Distribution of the
cross‐sectional areas of the cardiospheres, transduced either with AAV6‐MCS, ‐N1ICD or ‐sJ1, after 3, 5 and 7 days of in vitro culture. Shown
are Tukey boxplots. D, Gene expression profile of stem‐, vasculo‐ and cardio‐related genes in cardiospheres transduced either with AAV6‐MCS,
‐N1ICD or ‐sJ1 vectors, at days 3, 5 and 7 after plating. Data are expressed to cellular HPRT mRNA levels. Shown are the mean ± SEM of at
least 3 independent experiments. **P < 0.01: *P < 0.05
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likely reflected a requirement for sJ1 to accumulate in the extra-
cellular environment in order for the soluble ligand to cluster and
activate the Notch pathway.42,43 These results further support the
peculiar role of the Notch pathway in CSp growth.
To elucidate the gene expression programme activated upon viral
transduction, we analysed gene expression of transduced CSps at 3,
5 and 7 days of culture. Both AAV vectors triggered a gene expres-
sion programme (Figure 4D) superimposable to the one observed
upon sJ1 stimulation (cf. Figure 3E), further supporting the role of
Notch1 in the expansion of a pool of cells putatively committed to a
cardiovascular fate.
3.6 | miR‐199a‐3p induces Notch expression, while
miR‐590‐3p enhances CSp growth and cardiovascular
commitment
A previous whole‐genome, synthetic miRNA screening conducted
in our laboratory identified several human miRNAs capable of
inducing significant proliferation of rodent cardiomyocytes. Of
interest, at least two of these miRNAs, miR‐199a‐3p and miR‐590‐
3p induced cardiac regeneration after myocardial infarction using
AAV‐mediated gene transfer26 or delivery of naked miRNA mim-
ics.44 Notably, the molecular mechanism by which these miRNAs
function in adult cardiomyocytes does not involve reactivation of
the Notch pathway.24 We therefore investigated whether the most
effective miRNAs in inducing neonatal and adult cardiomyocyte
proliferation (hsa‐miR‐199‐3p, hsa‐miR‐590‐3p, hsa‐miR‐1825, hsa‐
miR‐33b‐3p) activated the Notch pathway and played functional
roles in CSps.
CSp‐forming cells were transfected with the miRNAs contextually
to plating and analyses were performed after 3, 5 and 7 days of cul-
ture. MiR‐199a‐3p, miR‐590‐3p and miR‐33b‐3p triggered a signifi-
cant rise in the number and size of CSps at all time points. Of note,
miR‐1825 exerted a unique effect, inducing the formation of a small
number of very large CSps (Figure 5A, B, C). Gene expression analy-
sis revealed increased Notch1 transcript levels as a result of each of
the four miRNAs tested, with the highest effect observed using miR‐
199a‐3p. This miRNA induced gene overexpression of Notch1 (2.3
fold over control), Jagged1 (2.1 fold over control), Dll‐1 (3 fold over
control) and Hes1 (4 fold over control) after day 3 of culture (Fig-
ure 5D).
To streamline a common effect of the miRNAs of interest that
could explain their similar effect on cardiosphere growth, possibly
involving the Notch signalling pathway, we annotated the genes
known to be differentially involved in the regulation of the Notch
pathway (Gene Ontology database‐GO:0007219), in particular the
negative regulators (GO:0045746), and compared them with the
RNAseq data available in our laboratory, obtained by deep sequenc-
ing of RNA from rodent cardiac cells after treatment with miR‐590‐
3p, miR‐199a‐3p, miR‐33b and miR‐1825 (unpublished data). We
focused our attention on Neurl1a and Dner, a ligand‐specific ubiqui-
tin ligase and an atypical Notch ligand, respectively, both involved to
a various extent in the negative modulation of Notch signalling in
various cellular contexts [for a review see Refs. 28,50,51,52,53]. This
choice supported by the cosideration that the biological effect of
each of the four miRNAs is pleiotropic, and thus the individual
molecular route of action involves targeting of several different play-
ers in the same pathway(s). Figure S4 shows the bioinformatic target
predictions (panels A and B) as a support of the clear downregula-
tion of the Neurl1a and Dner transcripts in cardiospheres transfected
with miR‐199a‐3p, miR‐590‐3p, miR‐1825 and miR‐33b‐3p mimics
after day 3 of culture (panel C). These results support the conclusion
that the most effective miRNAs in inducing cardiomyocyte prolifera-
tion exert a pro‐proliferative effect in CSps, broadly interfering with
the Notch pathway regulation.
We then investigated the potential of miRNAs to induce a
cardio‐specific differentiation programme. Three days after transfec-
tion, miR‐590‐3p strongly induced both early (Gata4 and Nkx2.5)
and late cardiac markers (Myh6), along with the vascular marker
CD31. Interestingly, miR‐590‐3p upregulated both Sca1 and CD117
transcription, suggesting a possible role for this miRNA as a positive
regulator of the expansion of the pool of proliferating progenitors,
which likely accounted for the observed increase in CSp size (Fig-
ure 5E).
To further characterize the effects of miR‐590 on CSps, we
investigated cell proliferation. Interestingly, miR‐590‐3p transfection
was associated with a two‐fold increase in EdU+/Gata4+ cells
within CSps at day 3 of culture, which correlated with the
observed upregulation of GATA4 transcripts (Figure 5F, panels a
and b).
Collectively, these data support the notion that different miRNAs
play distinct roles in CSp formation as an in vitro model of early car-
diac development. MiR‐199a‐3p acts as a potent stimulus for the
activation of the Notch pathway at early time points, whereas it
loses its effect at later stages of CSp differentiation.8,18,33 On the
other hand, miR‐590‐3p specifically promotes a cardiovascular differ-
entiation programme, leading to the expansion of a pool of Sca1+ or
CD117+ cells, and expression of cardiovascular differentiation
markers.
4 | DISCUSSION
The mammalian heart is unable to compensate for a massive loss
of cardiomyocytes after injury. This is due to a dramatic decrease
in the proliferative capability of mature cardiomyocytes, compared
to neonatal conditions and to the poor regenerative potential of
CPCs. Several approaches are under investigation to induce car-
diomyocyte proliferation or progenitor activation and expansion.
One of these approaches aims at expanding autologous progenitors
cells from minimally invasive cardiac biopsies for cell therapy in
patients after myocardial infarction (cf. CADUCEUS phase I trial
Clinicaltrials.gov‐NCT00893360). This strategy was inspired by a
seminal study by E. Messina and co‐workers,19 which established
the experimental technique for in vitro growth of progenitor cells
isolated from myocardial biopsies. The so‐called CSps and CSp‐
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F IGURE 5 miR‐199a induces Notch signalling and enhances cardiosphere growth to a cardio‐vascular fate. Cardiosphere‐forming cells were
transfected contextually to plating with either cel‐miR‐67 (control), miR‐199a‐3p, miR‐590‐3p, miR‐1825 or miR‐33b‐3p. Analyses were
performed 3, 5 and 7 days after plating. A, Representative bright field images of cardiospheres, transfected with either celmiR‐67 (control),
miR‐199a‐3p, miR‐590‐3p, miR‐1825 or miR‐33b‐3p, after 3, 5 and 7 days of in vitro culture. Scale bar: 100 μm. B, Quantification of the
number of cardiospheres formed upon miRNA transfection, 3, 5 and 7 days of in vitro culture. Shown are mean ± SEM of at least 3
experimental replicates. **P < 0.01: *P < 0.05. C, Distribution of the cross‐sectional areas of the cardiospheres, transfected with either cel‐
miR‐67 (control), miR‐199a‐3p, miR‐590‐3p, miR‐1825 or miR‐33b‐3p, after 3, 5 and 7 days of in vitro culture. Shown are Tukey boxplots. D,
Transcription levels of Notch receptors, ligands and the indicated target genes in cardiospheres analysed at day 3, 5 and 7 of culture, following
transfection of either cel‐miR‐67 (control), miR‐199a‐3p, miR‐590‐3p, miR‐1825 or miR‐33b‐3p. Data are expressed to cellular HPRT mRNA
levels. Shown are the mean ± SEM of at least 3 independent experiments. **P < 0.01: *P < 0.05. E, gene expression analysis of stemness and
cardio‐vascular markers in cardiospheres analysed after 3 days of culture, following transfection of either cel‐miR‐67 (control), miR‐199a‐3p,
miR‐590‐3p, miR‐1825 or miR‐33b‐3p. Data are expressed to cellular HPRT mRNA levels. Shown are the mean ± SEM of at least 3
independent experiments. **P < 0.01: *P < 0.05. F, (a) Representative images of cardiospheres analysed after 3 days of in vitro culture,
following transfection of either celmiR‐67 (control), miR‐199a‐3p, miR‐590‐3p. Gata4 (green), EdU (red), nuclei (blue). Bars: 100 μm. (b)
Quantification of Gata4+ and EdU+ cells upon cel‐miR‐67 (control), miR‐199a‐3p and miR‐590‐3p transfection. Shown are mean ± SEM of at
least 3 experimental replicates. **P < 0.01: *P < 0.05
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derived cells produced using this technique are valuable tools for
studying cardiac progenitor cell biology.
Here we have exploited the CSp model to investigate the role
of the Notch pathway in the cardiovascular differentiation pro-
gramme. Previous gene expression studies have shown a pheno-
typic heterogeneity of the cellular components of CSps.45,46
Consistent with these findings, we detected Sca‐1 positive cells,
along with cells that were more committed towards vasculo‐
endothelial or cardiac fate specification. Previous evidence from
our group and other laboratories have demonstrated a peculiar role
of the Notch pathway in the expansion of the undifferentiated
precursor cell pool in the heart and in the regulation of neonatal
cardiomyocyte proliferation both in vitro and in vivo.10,12,16,29,30
Given the poorly differentiated molecular signature of the cell
components of CSps, we wondered whether Notch signalling was
involved in the regulation of CSp growth. Interestingly, we found a
peculiar spatial distribution of different key molecules in the Notch
pathway: immunostaining for Notch 1 and 2 receptors revealed a
patchy distribution, whereas Hes1 expression was localized in the
deep core of the spheres. Conversely, the ligands Jagged1 and
Delta‐like1 were expressed by cells located in the outer layer of
the spheres. We then either stimulated the Notch pathway with
the soluble ligand Jagged1 (sJ1) or blocked its activation by inhibit-
ing γ‐secretase processing with DAPT. The number and size of
CSps was significantly increased after sJ1 treatment, with an over-
all upregulation of genes involved in cardiovascular development.
DAPT, on the contrary, completely reversed this effect. We then
decided to validate these results using a gene transfer approach
involving AAV‐mediated transduction of CSp‐forming cells with
either sJ1 or the activated intracellular domain of Notch1 (N1‐
ICD). In both cases, we detected a net increase in both numbers
and size of transduced CSps, which was associated with activation
of a peculiar genetic programme promoting cardiovascular differen-
tiation.
Multiple evidence over the last few years has shown a pivotal
role of the microRNA network in the control of most biological func-
tions of heart cells.47,48 In particular, a previous whole‐genome, syn-
thetic miRNA screening conducted in our laboratory revealed several
human miRNAs capable of inducing significant proliferation of
neonatal rat and mouse CMs.26 Among these miRNAs, miR‐199a‐3p,
miR‐590‐3p and miR‐1825, have been shown to be involved in the
regulation of embryonic cell proliferation49 and were capable to
induce cardiac regeneration after myocardial infarction (MI), either
when expressed using AAV‐mediated gene transfer26 or delivered as
naked miRNA mimics.44 Remarkably, the molecular mechanisms by
which the most effective pro‐proliferative miRNAs function in adult
cardiomyocytes do not involve reactivation of the Notch pathway.24
We therefore wondered whether they could play a functional role in
CSps, acting through multiple, specific pathways. All the miRNAs of
interest shared a common effect on CSps, triggering a significant
increase in their number and size. Gene expression analysis revealed
increased levels of genes of the Notch pathway at the earliest time
points of in vitro culture, as a result of each of the four miRNAs
tested, suggesting this pathway as a possible target of either direct
or indirect regulation by these miRNAs. While the overall mechanism
of action of each miRNA is likely different, common pathways are
likely to exist. Among Notch signalling negative regulators
(GO:0045746), we found several different genes predicted to be dif-
ferentially downregulated by each of the miRNAs of interest. In par-
ticular, we validated as possible targets Neurl1a, a ligand‐specific
ubiquitin ligase50,51 and Dner, coding for a atypical Notch
ligand.28,52,53 In both cases, a net downregulation of the transcripts
for these genes was observed after expression of all the tested miR-
NAs.
Collectively, our data show that the Notch pathway drives the
proliferation of CSp‐forming cells. Exogenous activation of this
pathway magnifies these effects and causes a shift of the gene
expression profile towards genes involved in cardiovascular differ-
entiation.
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